Abstract:Abstract Background Alzheimer’s disease (AD) is a complex pathophysiological disease. Its progression is heterogenous and associated with clinical symptoms as well as prognosis. Hence, understanding the progression of AD is important in guiding patient management, evaluating treatment response and designing therapeutic trials. We developed and validated a novel machine learning model for revealing the underlying disease progression patterns from longitudinal multi-modal data of AD. Methods The prospective ADNI study data (1192 patients with cognitive impairment and 388 healthy controls) was used to train, validate and test a novel personalized hidden Markov model to identify disease-related states. The transition diagram of disease-related states exhibited two distinct disease progression patterns. We used the index of disease-related states as a predictor, and evaluated the prediction performance on time to conversion to AD dementia. External validation was performed on the AIBL cohort (87 patients with cognitive impairment and 179 healthy controls). Findings Our model identified ten biologically and clinically meaningful disease-related states from longitudinal multi-modal data, which constitute three non-overlapping stages (i.e., neocortical atrophy [NCA], medial temporal atrophy [MTA], and whole brain atrophy [WBA]) and two distinct disease progression patterns (i.e., NCA→WBA and MTA→WBA) hidden in the trajectories of AD patients. Disclosed patterns showed different atrophy trends of brain regions, and presented distinct genetic, clinical and biomarker characteristics, especially in the early course of the disease. The index of the identified disease-related states provided a remarkable performance on predicting the time to conversion to AD dementia (C-Index: 0.923±0.007), in comparison with the other commonly recognized AD risk factors, including APOE (0.607±0.012), MMSE score (0.808±0.006), Abeta (0.7445±0.013), pTau (0.689±0.006), and hippocampal volume (0.774±0.010). Interpretation A machine learning algorithm was proposed to capture the full spectrum of AD progression by identifying meaningful AD-related states as well as distinct disease progression patterns from longitudinal multi-modal data, showing its potential for promoting the understanding of heterogeneous disease progression, and early predicting the conversion time to AD dementia.

Modeling Disease Progression via Multisource Multitask Learners: A Case Study With Alzheimer's Disease.

Beyond Doctors: Future Health Prediction from Multimedia and Multimodal Observations.

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network

Modeling disease progression via multi-task learning

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer's disease progression

Multi-modal Sequence Learning for Alzheimer's Disease Progression Prediction with Incomplete Variable-Length Longitudinal Data.

Multi-modal sequence learning for Alzheimer’s disease progression prediction with incomplete variable-length longitudinal data

Spatio-Temporal Similarity Measure based Multi-Task Learning for Predicting Alzheimer's Disease Progression using MRI Data

Modeling Disease Progression with Deep Neural Networks.

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

Modeling Disease Progression via Fused Sparse Group Lasso

Toward a multimodal multitask model for neurodegenerative diseases diagnosis and progression prediction

Modeling and Predicting AD Progression by Regression Analysis of Sequential Clinical Data.

Modeling Alzheimers' Disease Progression from Multi-task and Self-supervised Learning Perspective with Brain Networks

MAPPING ALZHEIMER'S DISEASE PSEUDO-PROGRESSION WITH MULTIMODAL BIOMARKER TRAJECTORY EMBEDDINGS

Modeling Alzheimer’s Disease Progression with Fused Laplacian Sparse Group Lasso

Healthcare Predictive Analytics for Disease Progression: a Longitudinal Data Fusion Approach

A Probabilistic Disease Progression Model for Predicting Future Clinical Outcome

Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data

Spatio-temporal Tensor Multi-Task Learning for Predicting Alzheimer's Disease in a Longitudinal study